Additionally, the first intracellular signalling regulator found to interact with MVP was the PI3K antagonist and tumour suppressor PTEN [24], frequently deregulated in human GBM by gene deletion, mutation, promoter methylation or miRNA mediated suppression [41, 42]. The gene discussed is MVP; the disease is glioblastoma.